Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'Real Thyroid Carcinomas'

Journal of Clinical Pathology

Volumn 66, Issue 9, 2013, Pages 733-743

  Baloch, Zubair ^a   Li Volsi, Virginia A ^b   Tondon, Rashmi ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; MICRORNA; RADIOACTIVE IODINE; THYROGLOBULIN; TRANSCRIPTION FACTOR EZH2; UVOMORULIN;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CELL FUNCTION; CELL LINEAGE; CHERNOBYL ACCIDENT; ELECTRON MICROSCOPY; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MICROSCOPY; MITOSIS RATE; MOLECULAR DYNAMICS; PATHOGENESIS; PATHOLOGIST; PRIORITY JOURNAL; PSAMMOMA BODY; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT RESPONSE; TUMOR CELL; WORLD HEALTH ORGANIZATION;

NEOPLASMS; SURGICAL PATHOLOGY; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; HUMANS; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84882887039     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201626     Document Type: Review

References (107)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Ann Surg Oncol 2012;19:1874-80.
3. DeLellis RA, Lloyd RD, Heitz PU, et al. eds. WHO: pathology and genetics. Tumours of endocrine organs. Lyon, France: IARC Press, 2004.
4. LiVolsi VA. Papillary thyroid carcinoma: An update. Mod Pathol 2011;24(Suppl 2):S1-9.
5. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
6. van den Brekel MW, Hekkenberg RJ, Asa SL, et al. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 1997;107:254-9.
7. LiVolsi VA. Papillary carcinoma tall cell variant (TCV): A review. Endocr Pathol 2010;21:12-15.
8. Silver CE, Owen RP, Rodrigo JP, et al. Aggressive variants of papillary thyroid carcinoma. Head Neck 2011;33:1052-9.
9. Abrosimov A, Kozhushnaia SM. Papillary thyroid carcinoma from tall and columnar cells. Arkh Patol 2011;73:50-4.
10. Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 2000;88:1902-8.
11. Hawk WA HJ. The many appearances of papillary carcinoma of the thyroid. Clev Clin Q 1976;43:207-16.
12. Ghossein R, Livolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid 2008;18:1179-81.
13. Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol 2002;27:143-8.
14. Ghossein RA, Leboeuf R, Patel KN, et al. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid 2007;17:655-61.
15. Rivera M, Ghossein RA, Schoder H, et al. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 2008;113:48-56.
16. Johnson TH, Thompson LR, Beierwalters NW WH, et al .prognostic implications of the tall cell variant of papillary carcinoma. Am J Surg Pathol 1988;12:22-7.
17. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. Cancer 1983;52:1849-55.
18. Jalisi S, Ainsworth T, Lavalley M. Prognostic outcomes of tall cell variant papillary thyroid cancer: A meta-analysis. J Thyroid Res 2010;2010:325602.
19. Rivera M, Ricarte-Filho J, Tuttle RM, et al. Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 2010;20:1085-93.
20. Wreesmann VB, Sieczka EM, Socci ND, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res 2004;64:3780-9.
21. Chen Y, Zhu M, Zhou X, et al. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, Galectin-3 and Mucin-1 genes]. Zhonghua Yi Xue Za Zhi 2002;82:257-61.
22. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399-404.
23. Filie AC, Chiesa A, Bryant BR, et al. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer 1999;87:238-42.
24. Basolo F, Giannini R, Monaco C, et al. Potent Mitogenicity of the RET/PTC3 Oncogene Correlates with Its Prevalence in Tall-Cell Variant of Papillary Thyroid Carcinoma. Am J Pathol 2002;160:247-54.
25. Gaertner EM, Davidson M, Wenig BM. The columnar cell variant of thyroid papillary carcinoma. Case report and discussion of an unusually aggressive thyroid papillary carcinoma. Am J Surg Pathol 1995;19:940-7.
26. Wenig BM, Thompson LD, Adair CF, et al. Thyroid papillary carcinoma of columnar cell type: A clinicopathologic study of 16 cases. Cancer 1998;82:740-53.
27. Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 1986;85:77-80.
28. LiVolsi VA. surgical pathology of the thyroid Philadelphia, PA: WB. Saunders, 1990.
29. LiVolsi VA. Unusual variants of papillary thyroid carcinoma. Adv Endocrinol Metab 1995;6:39-54.
30. Sujoy V, Pinto A, Kovacs CM, et al. CDX2 is rarely expressed in columnar cell variant of papillary thyroid carcinoma: A study of ten cases. Mod Pathol 2011;24(Suppl 1):142A.
31. Enriquez ML, Baloch Z, Montone KT, et al. CDX2 Expression in Columnar Cell Variant of Papillary Thyroid Carcinoma. Am J Clin Pathol 2012;137:722-6.
32. Evans HL. Encapsulated columnar-cell carcinoma of the thyroid. A report of four cases suggesting a favorable outcome. Am J Surg Pathol 1996;20:1205-11.
33. Chen JH, Faquin WC, Lloyd RV, et al. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma. Mod Pathol 2011;24:739-49.
34. Vickery AL Jr, Carcangiu ML, Johannessen JV, et al. Papillary carcinoma. Semin Diagn Pathol 1985;2:90-100.
35. Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid 2009;19:1225-31.
36. McElvanna K, McCusker G, Stirling I. Diffuse sclerosing variant of papillary thyroid carcinoma-A rare cause of goitre in a young patient. Ulster Med J 2007;76:113-14.
37. Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: A 35-year comparative study at a single institution. Ann Surg Oncol 2006;13:176-81.
38. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 1989;13:1041-9.
39. Soares J, Limbert E, Sobrinho-Simoes M. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract 1989;185:200-6.
40. Zhang Y, Xia D, Lin P, et al. Sonographic findings of the diffuse sclerosing variant of papillary carcinoma of the thyroid. J Ultrasound Med 2010;29:1223-6.
41. Siegal A, Mimouni M, Kovalivker M, et al. Latent childhood thyroid carcinoma in diffuse lymphocytic thyroiditis. J Surg Oncol 1983;23:155-7.
42. Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: A multi-institutional analysis of 40 cases. Cancer 2009;117:185-94.
43. Matias-Guiu X, Esquius J. Aberrant expression of HLA-DR antigen in diffuse sclerosing variant of papillary carcinoma of thyroid. J Clin Pathol 1989;42:1309.
44. Regalbuto C, Malandrino P, Tumminia A, et al. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid 2011;21:383-9.
45. Rocha AS, Soares P, Seruca R, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 2001;194:358-66.
46. Sheu SY, Schwertheim S, Worm K, et al. Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 2007;20:779-87.
47. Nikiforov YE, Rowland JM, Bove KE, et al. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997;57:1690-4.
48. Nikiforov YE. Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med 2011;135:569-77.
49. Lin X, Finkelstein SD, Zhu B, et al. Molecular analysis of multifocal papillary thyroid carcinoma. J Molecular Endocrinol 2008;41:195-203.
50. Fridman MV, Savva NN, Krasko OV, et al. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of belarus. Thyroid 2012;22:1016-24.
51. LiVolsi VA, Abrosimov AA, Bogdanova T, et al. The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol) 2011;23:261-7.
52. Nikiforov YE, Erickson LA, Nikiforova MN, et al. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 2001;25:1478-84.
53. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol 1984;8:655-68.
54. Albores-Saavedra J, Housini I, Vuitch F, et al. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer 1997;80:1110-16.
55. Ashfaq R, Vuitch F, Delgado R, et al. Papillary and follicular thyroid carcinomas with an insular component. Cancer 1994;73:416-23.
56. Elisei R, Romei C, Vorontsova T, et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 2001;86:3211-16.
57. Trovisco V, Soares P, Soares R, et al. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 2005;36:694-7.
58. Chiosea S, Nikiforova M, Zuo H, et al. A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol 2009;20:122-6.
59. Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010;34:44-52.
60. Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: A new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol 2010;34:913; author reply 4.
61. Rosai J, Carcangui ML, DeLellis RA. Tumors of the thyroid gland. Washington, DC: Armed Forces Institute of Pathology, 1992.
62. Ivanova R, Soares P, Castro P, et al. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: A clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma. Virchows Arch 2002;440:418-24.
63. Mizukami Y, Nonomura A, Michigishi T, et al. Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology 1995;27:575-7.
64. Chan JK, Tsang WY. Endocrine malignancies that may mimic benign lesions. Semin Diagn Pathol 1995;12:45-63.
65. Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Arch Otolaryngol Head Neck Surg 2012;138:227-33.
66. Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 2010;23:1269-78.
67. Granner DK, Buckwalter JA. Poorly differentiated carcinoma of the thyroid gland. Surg Gynecol Obstet 1963;116:650-6.
68. Sobrinho-Simoes M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 1988;89:264-7.
69. Habib K, Auriol M, Sarfati E, et al. Undifferentiated carcinomas of the thyroid corpus. Apropos of 10 cases. Arch Anat Cytol Pathol 1993;41:129-39.
70. Fonseca E, Sobrinho-Simoes M. Diagnostic problems in differentiated carcinomas of the thyroid. Pathol Res Pract 1995;191:318-31.
71. Papotti M, Torchio B, Grassi L, et al. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol 1996;20:686-94.
72. Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: A clinicopathologic study of 183 patients. Cancer 2004;100:950-7.
73. Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: An incubating entity. Frontiers in endocrinology. Epub 2012;3:77.
74. Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol 2011;35:1866-72.
75. Basolo F, Pisaturo F, Pollina LE, et al. N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 2000;10:19-23.
76. Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol 2011;22:190-4.
77. Bongiovanni M, Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: A cytologic-histologic review. Adv Anatomic Pathol 2009;16:283-9.
78. Pietribiasi F, Sapino A, Papotti M, et al. Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol 1990;94:687-92.
79. Volante M, Rapa I, Gandhi M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 2009;94:4735-41.
80. Soares P, Trovisco V, Rocha AS, et al. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 2004;444:572-6.
81. Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy. Head Neck 2010;32:829-36.
82. Chiacchio S, Lorenzoni A, Boni G, et al. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol 2008;33:341-57.
83. Chang TC, Liaw KY, Kuo SH, et al. Anaplastic thyroid carcinoma: review of 24 cases, with emphasis on cytodiagnosis and leukocytosis. Taiwan Yi Xue Hui Za Zhi 1989;88:551-6.
84. Carcangiu ML, Steeper T, Zampi G, et al. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985;83:135-58.
85. Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 2011;21:1183-9.
86. Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 2012;36:1247-54.
87. Edge SB; American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 7th edn. New York; London: Springer, 2010.
88. Venkatesh YS, Ordonez NG, Schultz PN, et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66:321-30.
89. Kobayashi S, Yamadori I, Ohmori M, et al. Anaplastic carcinoma of the thyroid with osteoclast-like giant cells. An ultrastructural and immunohistochemical study. Acta Pathol Jpn 1987;37:807-15.
90. Vassilatou E, Fisfis M, Morphopoulos G, et al. Papillary thyroid carcinoma producing granulocyte-macrophage colony-stimulating factor is associated with neutrophilia and eosinophilia. Hormones (Athens) 2006;5:303-9.
91. Wan SK, Chan JK, Tang SK. Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis. Am J Clin Pathol 1996;105:388-93.
92. LiVolsi VA, Brooks JJ, Arendash-Durand B. Anaplastic thyroid tumors. Immunohistology. Am J Clin Pathol 1987;87:434-42.
93. Beltrami CA, Criante P, Di Loreto C. Immunocytochemistry of anaplastic carcinoma of thyroid gland. Appl Pathol 1989;7:122-33.
94. Miettinen M, Franssila KO. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Human Pathol 2000;31:1139-45.
95. Gopal PP, Montone KT, Baloch Z, et al. The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. Thyroid 2011;21:493-9.
96. Casterline PF, Jaques DA, Blom H, et al. Anaplastic giant and spindle-cell carcinoma of the thyroid: A different therapeutic approach. Cancer 1980;45:1689-92.
97. Kapp DS, LiVolsi VA, Sanders MM. Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations. Yale J Biol Med 1982;55:521-8.
98. Wolf BC, Sheahan K, DeCoste D, et al. Immunohistochemical analysis of small cell tumors of the thyroid gland: An Eastern Cooperative Oncology Group study. Hum Pathol 1992;23:1252-61.
99. Perri F, Lorenzo GD, Scarpati GD, et al. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol 2011;2:150-7.
100. Foote RL, Molina JR, Kasperbauer JL, et al. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: A single-institution experience using aggressive multimodal therapy. Thyroid 2011;21:25-30.
101. Rapkiewicz A, Roses D, Goldenberg A, et al. Encapsulated anaplastic thyroid carcinoma transformed from follicular carcinoma: A case report. Acta Cytol 2009;53:332-6.
102. Luze T, Totsch M, Bangerl I, et al. Fine needle aspiration cytodiagnosis of anaplastic carcinoma and malignant haemangioendothelioma of the thyroid in an endemic goitre area. Cytopathology 1990;1:305-10.
103. Saunders CA, Nayar R. Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: A potential pitfall. Diagn Cytopathol 1999;21:413-18.
104. Schneider V, Frable WJ. Spindle and giant cell carcinoma of the thyroid: cytologic diagnosis by fine needle aspiration. Acta Cytol 1980;24:184-9.
105. Vinette DS, MacDonald LL, Yazdi HM. Papillary carcinoma of the thyroid with anaplastic transformation: diagnostic pitfalls in fine-needle aspiration biopsy. Diagn Cytopathol 1991;7:75-8.
106. Borbone E, Troncone G, Ferraro A, et al. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab 2011;96:1029-38.
107. Esposito F, Tornincasa M, Pallante P, et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 2012;97: E710-18.